{
    "root": "df03067f-7374-4da4-852f-827a421a41d2",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Duopa",
    "value": "20250507",
    "ingredients": [
        {
            "name": "Levodopa",
            "code": "46627O600J",
            "drugbank_id": "https://go.drugbank.com/drugs/DB01235"
        },
        {
            "name": "Carbidopa",
            "code": "MNX7R8C5VO",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3395"
        },
        {
            "name": "CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM",
            "code": "K679OBS311",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_85146"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        }
    ],
    "indications": {
        "text": "duopa\u00ae indicated treatment motor fluctuations patients advanced parkinson \u2019 disease .",
        "doid_entities": [
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "maximum recommended daily dose duopa 2000 mg levodopa ( i.e . , one cassette per day ) administered 16 hours ( 2.1 ) prior initiating duopa , convert patients forms levodopa oral immediate-release carbidopa-levodopa tablets ( 1:4 ratio ) ( 2.2 ) titrate total daily dose based response patient ( 2.2 ) administer duopa jejunum percutaneous endoscopic gastrostomy jejunal tube ( peg-j ) cadd\u00ae-legacy 1400 portable infusion pump ( 2.3 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "single-use cassettes containing 4.63 mg carbidopa ( 5 mg monohydrate ) 20 mg levodopa per ml enteral suspension . cassette contains approximately 100 ml suspension . carton 7 duopa cassettes : ndc 0074-3012-07",
    "adverseReactions": "duopa contraindicated patients currently taking nonselective monoamine oxidase ( mao ) inhibitor ( e.g . , phenelzine tranylcypromine ) recently ( within 2 weeks ) taken nonselective mao inhibitor . hypertension occur drugs used concurrently [ ( 7.1 7.2 ) ] .",
    "indications_original": "DUOPA\u00ae is indicated for the treatment of motor fluctuations in patients with advanced Parkinson\u2019s disease.",
    "contraindications_original": "The maximum recommended daily dose of DUOPA is 2000 mg of levodopa (i.e., one cassette per day) administered over 16 hours ( 2.1 ) Prior to initiating DUOPA, convert patients from all forms of levodopa to oral immediate-release carbidopa-levodopa tablets (1:4 ratio) ( 2.2 ) Titrate total daily dose based on clinical response for the patient ( 2.2 ) Administer DUOPA into the jejunum through a percutaneous endoscopic gastrostomy with jejunal tube (PEG-J) with the CADD\u00ae-Legacy 1400 portable infusion pump ( 2.3 )",
    "warningsAndPrecautions_original": "Single-use cassettes containing 4.63 mg carbidopa (as 5 mg of the monohydrate) and 20 mg levodopa per mL of enteral suspension. Each cassette contains approximately 100 mL of suspension. \n                        Carton of 7 DUOPA cassettes: NDC 0074-3012-07",
    "adverseReactions_original": "DUOPA is contraindicated in patients who are currently taking a nonselective monoamine oxidase (MAO) inhibitor (e.g., phenelzine and tranylcypromine) or have recently (within 2 weeks) taken a nonselective MAO inhibitor. Hypertension can occur if these drugs are used concurrently [see Drug Interactions (\n                     \n                        7.1\n                     \n                      and \n                     \n                        7.2\n                     \n                     )].",
    "drug": [
        {
            "name": "Duopa",
            "drugbank_id": "https://go.drugbank.com/drugs/DB01235"
        }
    ]
}